Illumina Inc ILMN:NASDAQ

Last Price$372.84NASDAQ Closing Price as of 3:59PM ET 5/12/21
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change-8.67(2.27%)
Bid (Size)$370.04 (69)
Ask (Size)$383.89 (1)
Day Low / High$371.00 - 382.03
Volume817.7 K
 

View Biotechnology IndustryPeer Comparison as of 05/12/2021

 

Illumina Inc ( NASDAQ )

Price: $372.84
Change: -8.67 (2.27%)
Volume: 817.7 K
3:59PM ET 5/12/2021
 
 

Vertex Pharmaceuticals Inc ( NASDAQ )

Price: $212.68
Change: -0.32 (0.15%)
Volume: 1.2 M
4:00PM ET 5/12/2021
 
 

Regeneron Pharmaceuticals Inc ( NASDAQ )

Price: $507.14
Change: +5.95 (1.19%)
Volume: 967.8 K
3:59PM ET 5/12/2021
 
 

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A
N/A
 
 

Moderna Inc ( NASDAQ )

Price: $152.65
Change: -6.34 (3.99%)
Volume: 5.7 M
4:15PM ET 5/12/2021
 

Read more news Recent News

Significant Insider Sales in Shares of Illumina (ILMN) Extends the Selling Trend of Last Quarter
10:20PM ET 5/07/2021 MT Newswires

Two insiders -- Jay T Flatley, Director, and Susan H Tousi, Officer -- today, sold 4,300 shares of Illumina having a market value of approximately...

Insider Trends: Illumina Sees 90 Days of Insider Buying Trend Scaling Back with Share Sale
5:24PM ET 5/06/2021 MT Newswires

Jay T Flatley, Director, reported a sale of 4,000 shares in Illumina (ILMN) on May 04, 2021, for $1,536,600. Flatley, following the transactions...

Illumina Challenges European Commission Decision to Review GRAIL Acquisition
10:01AM ET 4/29/2021 MT Newswires

Illumina (ILMN) has asked the General Court of the European Union to annul the European Commission's April 19 decision to review the company's proposed...

--Canaccord Genuity Adjusts Illumina PT to $470 From $460, Maintains Buy Rating
1:14PM ET 4/28/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Company Profile

Business DescriptionIllumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA. View company web site for more details
Address5200 Illumina Way
San Diego, California 92122
Phone+1.858.202.4500
Number of Employees7,300
Recent SEC Filing05/12/2021425
President, Chief Executive Officer & DirectorFrancis A. deSouza
Chief Operations OfficerRobert P. Ragusa
Chief Financial Officer & Senior Vice PresidentSam A. Samad
Chief Medical OfficerPhillip G. Febbo

Company Highlights

Price Open$374.70
Previous Close$381.51
52 Week Range$260.42 - 555.77
Market Capitalization$54.4 B
Shares Outstanding146.0 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement08/05/2021

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / Earnings89.71
Earnings per Share$3.06
Beta vs. S&P 500N/A
Revenue$3.3 B
Net Profit Margin18.14%
Return on Equity13.35%

Analyst Ratings as of 03/31/2021

Buy
6
Overweight
0
Hold
9
Underweight
1
Sell
4
Consensus RecommendationConsensus Icon
Powered by Factset